Gambaran Interaksi Obat Pada Pasien Diabetes Mellitus Tipe 2 di Rumah Sakit X

Fajrin Noviyanto; Rita Mintarsih; Farahdina Chairani

doi:10.37311/jsscr.v5i2.21578

Gambaran Interaksi Obat Pada Pasien Diabetes Mellitus Tipe 2 di Rumah Sakit X

Fajrin Noviyanto, Rita Mintarsih, Farahdina Chairani

Abstract

Diabetes mellitus is a chronic condition characterized by higher than normal blood glucose levels and problems with protein, carbohydrate, and lipid metabolism caused by a relative or total lack of the hormone insulin. In addition, as a result of more prescriptions being written, the danger of drug interactions increases due to potential interactions among diabetic inpatients. The purpose of this study was to describe drug interactions in patients with Type 2 Diabetes Mellitus at X Hospital in the period January-March 2023. Data taken retrospectively from medical records were used in this kind of study, and Lexicomp Interact Online was used to evaluate drug interaction data. The results of this study showed that females 46-55 experienced. Most drug interactions in the hospital. Based on lexicomp interact online, drug interactions were categorized into 3 categories, B minor (23.6%), C moderate (62.5%) and D major (13.9%). This study may encourage healthcare workers to increase their awareness to counteract drug interactions in diabetic patients with complications to improve their clinical outcomes.

Keywords

Dibetic; Lexicomp; Chronic disease

Full Text:

PDF

References

O. A. Poluan, W. I. Wiyono, and P. V. Y. Yamlean, “Identifikasi Potensi Interaksi Obat Pada Pasien Diabetes Melitus Tipe 2 Rawat Inap Di Rumah Sakit Gunung Maria Tomohon Periode Januari – Mei 2018,” Pharmacon, vol. 9, no. 1, p. 38, 2020, doi: 10.35799/pha.9.2020.27408.

T. I. M. Penyusun and T. Penyusun, “Pedoman Penatalaksanaan Diabetes Mellitus Tipe 2 pada Individu Dewasa di Bulan Ramadan Daftar Isi”.

K. R. Widiasari, I. M. K. Wijaya, and P. A. Suputra, “Diabetes Melitus Tipe 2: Faktor Risiko, Diagnosis, Dan Tatalaksana,” Ganesha Med., vol. 1, no. 2, p. 114, 2021, doi: 10.23887/gm.v1i2.40006.

K. Handayani and Y. Saibi, “Potensi Interaksi Obat Pada Resep Pasien Diabetes Melitus Rawat Jalan di RS X Jakarta Pusat,” Pharm. Biomed. Sci. J., vol. 1, no. 1, pp. 43–47, 2019, doi: 10.15408/pbsj.v1i1.12853.

B. Leny, “Evaluasi Interaksi Obat Pada Pasien Diabetes Melitus Tipe 2 Rawat Jalan Di Rumah Sakit Umum Daerah Provinsi NTB Tahun 2021,” vol. 4, no. 1, pp. 186–190, 2023.

N. Apriyan, A. Kridawati, and T. B. W. Rahardjo, “Hubungan Diabetes Mellitus Tipe 2 Dengan Kualitas Hidup Pralansia Dan Lansia Pada Kelompok Prolanis,” J. Untuk Masy. Sehat, vol. 4, no. 2, pp. 144–158, 2020, doi: 10.52643/jukmas.v4i2.1028.

R. A. DeFronzo et al., “Type 2 diabetes mellitus,” Nat. Rev. Dis. Prim., vol. 1, no. July, pp. 1–23, 2015, doi: 10.1038/nrdp.2015.19.

H. B. Febriyan, “Gaya hidup penderita diabetes mellitus Tipe 2 pada masyarakat di daerah perkotaan,” Wellness Heal. Mag., vol. 2, no. 2, pp. 361–368, 2020, doi: 10.30604/well.022.82000139.

F. Fitriani and S. Sanghati, “Intervensi Gaya Hidup Terhadap Pencegahan Diabetes Melitus Tipe 2 Pada Pasien Pra Diabetes,” J. Ilm. Kesehat. Sandi Husada, vol. 10, no. 2, pp. 704–714, 2021, doi: 10.35816/jiskh.v10i2.682.

Madania, N. Rasdianah, C. M. Dalu, and M. Pakaya, “Potensi Interaksi Obat Pasien Hipertensi dan Diabetes Mellitus tipe2 di Instalasi Rawat Jalan RSUD Toto Kabila,” Al-Idarah J. Manaj. dan Bisnis Islam, vol. 3, no. 1, pp. 59–60, 2022, [Online]. Available: Pharmacoscript Volume 5 No. 1 Februari 2022%0AMadania et al./ Pharmacoscript, Volume 5, No, 1, Februari 2022, 56-61

A. Marsela and A. W. Wisnu Wardaya, “Gambaran Potensial Interaksi Obat Pada Pasien Diabetes Millitus Dirawat Inap Rsud Linggajati,” J. Farmaku (Farmasi Muhammadiyah Kuningan), vol. 7, no. 1, pp. 19–25, 2022, doi: 10.55093/jurnalfarmaku.v7i1.255.

M. K. Murtiningsih, K. Pandelaki, and B. P. Sedli, “Gaya Hidup sebagai Faktor Risiko Diabetes Melitus Tipe 2,” e-CliniC, vol. 9, no. 2, p. 328, 2021, doi: 10.35790/ecl.v9i2.32852.

V. Nomor, W. S. Abdulkadir, E. N. Djuwarno, and N. Rasdianah, “Potensi Interaksi Obat Antidiabetes Melitus Tipe-2 dengan Obat,” vol. 5, pp. 245–252, 2023.

F. Nuraisyah, “Faktor Risiko Diabetes Mellitus Tipe 2,” J. Kebidanan dan Keperawatan Aisyiyah, vol. 13, no. 2, pp. 120–127, 2018, doi: 10.31101/jkk.395.

N. A. Prabowo et al., “Peningkatan Pengetahuan Diet Diabetes, Self Management diabetes dan Penurunan Tingkat Stres Menjalani Diet pada Pasien Diabetes Mellitus Tipe 2 di Rumah Sakit Universitas Sebelas Maret,” War. LPM, vol. 24, no. 2, pp. 285–296, 2021, doi: 10.23917/warta.v24i2.12515.

Refdanita and Maisarah, “Potensi Interaksi Obat Pada Pasien Diabetes Melitus Tipe 2 di Instalasi Rawat Jalan Salah Satu Rumah Sakit di Jakarta Selatan,” Sainstech Farma, vol. 10, no. 1, pp. 2–7, 2017.

E. Reinhard, M. T. Kamaluddin, and A. Melizah, “Potensi Terjadinya Interaksi Obat Antidiabetik Oral Pada Pasien Diabetes Melitus Tipe 2 Usia Lanjut,” Sriwij. J. Med., vol. 2, no. 3, pp. 205–210, 2019, doi: 10.32539/sjm.v2i3.83.

L. Silalahi, “Hubungan Pengetahuan dan Tindakan Pencegahan Diabetes Mellitus Tipe 2,” J. PROMKES, vol. 7, no. 2, p. 223, 2019, doi: 10.20473/jpk.v7.i2.2019.223-232.

DOI: https://doi.org/10.37311/jsscr.v5i2.21578

Refbacks

There are currently no refbacks.

EDITORIAL OFFICE OF JOURNAL SYIFA SCIENCES AND CLINICAL RESEARCH

Department of Pharmacy, Gorontalo State University

Jl. Jenderal Sudirman No.6, Kota Gorontalo, Provinsi Gorontalo 96128, Indonesia

Email: info.jsscr@ung.ac.id
Google Scholar : JOURNAL SYIFA SCIENCES AND CLINICAL RESEARCH

Journal Syifa Sciences and Clinical Research (JSSCR) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Username
Password
Remember me